NMRA
#3441
Neumora Therapeutics, Inc. - Common Stock
1.3 9 USD
-0.06%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-6.08%
Changement Mensuel
-15.76%
Evolution sur 6 mois
-51.23%
Changement Annuel
-20.11%
Clôture Précédente
1.4 8
Open
1.3 9
Low
1.3 9
High
1.3 9
Volume
42
Financials
- Market Capitalization 261.18 M
- Employee 63
- Founded 2019
- CEO N/A
- Website www.neumoratx.com
- Headquarter Delaware, United States
- FIGI BBG012W9C4X1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.23
ratio cours/chiffre d'affaires
-592.04
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3436 |  MGNX MacroGenics, Inc. - Common Stock | 4.13 USD | +1.23% | +1.47% | +10.13% | +133.33% | 263.08 M USD | ||
| 3440 |  ALEC Alector, Inc. - Common Stock | 2.34 USD | -2.09% | -0.85% | +53.95% | +1.74% | 261.28 M USD | ||
| 3445 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | +2.49% | +2.81% | +2.81% | -33.94% | 260.32 M USD | ||
| 3447 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.20 USD | -3.61% | -6.71% | -3.61% | +23.55% | 260.04 M USD |